An In-Depth Decentralized Trials Market Primer
The life sciences industry is perpetually driven to make drug development better, faster, and less expensive. Decentralized trials, where some or all study data are collected remotely via a device or wearable, have the potential to address each of these goals. This primer reviews what decentralized trials are, why they matter, and the extent to which they will be used in the future. It contains:
- A Market Overview of Decentralized (a.k.a. “Virtual”) Trials
- Benefits of and Barriers to Their Use
- The Impact of COVID-19 on Their Rate of Adoption
- Predictions of Industry Players on Their Post-COVID-19 Future